US hospital/GP interest in gainsharing on the wane?
This article was originally published in Clinica
As recently as last year, gainsharing was a hot-button idea in Washington, prompting a closed-door day-long policy briefing by AdvaMed on how the device industry might respond to what most device companies viewed as a potentially-damaging payment scheme. But now interest in gainsharing appears to be waning.
You may also be interested in...
An upturn in M&A activity across the whole healthcare sector is expected in 2021, with the COVID-19 pandemic and the associated development of a vaccine shining a light on the sector, says a recent survey by Jefferies.
Australian patients with phototoxicity due to the rare condition EPP will now have their first treatment option – provided the drug's developer, Clinuvel, secures reimbursement under the Pharmaceutical Benefits Scheme.
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.